In-vivo studies have demonstrated that focal loss of GLT-1 in the ventral horn of the spinal cord precedes disease onset in a transgenic rat model for ALS overexpressing SOD1 [18]. This evidence concerns the gene SLC1A2 and amyotrophic lateral sclerosis.